Studies show brain activity patterns influence effect of antidepressants
The psychiatry field has long sought answers to explain why antidepressants help only some people.
Is a patient’s recovery due merely to a placebo effect – the self-fulfilling belief that a treatment will work – or can the biology of the person influence the outcome?
Two studies led by UT Southwestern provide evidence for the impact of biology by using artificial intelligence to identify patterns of brain activity that make people less responsive to certain antidepressants. Put simply, scientists showed they can use imaging of a patient’s brain to decide whether a medication is likely to be effective.
The studies include the latest findings from a large national trial (EMBARC) intended to establish biology-based, objective strategies to remedy mood disorders and minimize the trial and error of prescribing treatments. If successful, scientists envision using a battery of tests such as brain imaging and blood analyses to increase the odds of finding the right treatment.
“We need to end the guessing game and find objective measures for prescribing interventions that will work,” said Dr. Madhukar Trivedi, who oversees EMBARC and is founding Director of UT Southwestern’s Center for Depression Research and Clinical Care. “People with depression already suffer from hopelessness, and the problem can become worse if they take a medication that is ineffective.”
The studies – which each included more than 300 participants – used imaging to examine brain activity in both a resting state and during the processing of emotions. Both studies divided the participants into a healthy control group and people with depression who either received antidepressants or placebo.
Of the participants who received medication, researchers found correlations between how the brain is wired and whether a participant was likely to improve within two months of taking an antidepressant.
Dr. Trivedi said imaging the brain’s activity in various states was important to get a more accurate picture of how depression manifests in a particular patient. For some people, he said, the more relevant data will come from their brains’ resting state, while in others the emotional processing will be a critical component and a better predictor for whether an antidepressant will work.
“Depression is a complex disease that affects people in different ways,” he said. “Much like technology can identify us through fingerprints and facial scans, these studies show we can use imaging to identify specific signatures of depression in people.”
Data from both studies derive from the 16-week EMBARC trial, which Dr. Trivedi initiated in 2012 at four U.S. sites. The project evaluated patients with major depressive disorder through brain imaging and various DNA, blood, and other tests. His goal was to address a troubling finding from another study he led (STAR*D) that found up to two-thirds of patients do not adequately respond to their first antidepressant.
EMBARC’s first study, published in 2018, focused on how electrical activity in the brain can indicate whether a patient is likely to benefit from an SSRI (selective serotonin reuptake inhibitor), the most common class of antidepressant.
The finding has been followed by related research that identifies other predictive tests for SSRIs, most recently the resting-state brain imaging study published in the American Journal of Psychiatry and the second imaging study published in Nature Human Behaviour.
AI and depression
The Nature research used artificial intelligence to determine correlations between the effectiveness of an antidepressant and how a patient’s brain processes emotional conflict.
Participants undergoing brain imaging were shown photographs in quick succession that offered sometimes conflicting messages such as an angry face with the word “happy,” or vice versa. Each participant was asked to read the word on the photograph before clicking to the next image.
However, rather than observe only neural regions believed to be relevant to predicting antidepressant benefits, scientists used machine learning to analyze activity in the entire brain. “Our hypotheses for where to look have not panned out, so we wanted to try something different,” Dr. Trivedi explained.
AI identified specific brain regions – for example in the lateral prefrontal cortices – that were most important in predicting whether participants would benefit from an SSRI. The results showed that participants who had abnormal neural responses during emotional conflict were less likely to improve within eight weeks of starting the medication.
Dr. Trivedi has initiated other large research projects to further understand the underpinnings of mood disorders, among them D2K, a study that will enroll 2,500 patients with depression and bipolar disorders and follow them for 20 years. In addition, RAD is a 10-year study of 2,500 participants (ages 10-24) that will uncover factors for reducing the risk of developing mood or anxiety disorders.
Utilizing some of these enrollees, Dr. Trivedi’s research team will study the results from several other tests to augment brain imaging and more accurately assess patients’ biological signatures to determine the most effective treatment. Dr. Trivedi has had preliminary success developing a blood test but acknowledges it may only benefit patients with a specific type of inflammation.
Combining blood and brain tests, he said, will improve the chances of choosing the right treatment the first time.
“We need to look at this issue in several ways to identify the many different signatures of depression in the body,” he said. “The findings from these new studies are significant and bring us closer to using them clinically to improve outcomes for millions of people.”
Learn more: AI helps scientists predict depression outcomes
The Latest on: Depression
via Google News
The Latest on: Depression
- Clinical Challenges: Treatment Combinations for Depressionon October 17, 2019 at 9:38 am
For treatment-resistant depression, knowing the options for combining therapies is a key challenge for healthcare providers. "You don't need to be a specialist, you don't need to be someone who is in ...
- Hippocampal proteomic changes of susceptibility and resilience to depression or anxiety in a rat model of chronic mild stresson October 17, 2019 at 9:36 am
Chronic stressful occurrences are documented as a vital cause of both depression and anxiety disorders. However, the stress-induced molecular mechanisms underlying the common and distinct ...
- Gustavus College presents great art from the Great Depressionon October 17, 2019 at 9:23 am
America in the 1930s was hardly as easy as apple pie. The nearly 100 photos and paintings in "Industry, Work, Society, and Travails in the Depression Era" at Gustavus Adolphus College artfully shine a ...
- Andrew Griggs murder trial: Wife 'suffered post-natal depression'on October 17, 2019 at 6:14 am
Andrew Griggs denies killing Debbie Griggs, who disappeared from their home in Deal, Kent, in May 1999. Mr Griggs, 57, told Canterbury Crown Court that his wife experienced post-natal depression and ...
- Tropical disturbance in Gulf shows increased chance of becoming a depressionon October 17, 2019 at 5:19 am
Chances of a tropical disturbance in the Gulf of Mexico forming into a depression have increased from 50% to 60% in just several hours, forecasters said Wednesday night. The system could move toward ...
- Florida gets tropical storm warning as next depression close to formationon October 17, 2019 at 5:16 am
A Tropical Storm Warning has been issued for parts of Florida as the tropical system in the southwestern Gulf of Mexico was given a 90 percent chance of becoming a tropical depression within the next ...
- NASCAR's Bubba Wallace on how heavy metal is helping him cope with depressionon October 17, 2019 at 3:58 am
People are still reaching out to NASCAR driver Darrell “Bubba” Wallace Jr. to thank him for opening up about his depression months after first publicly acknowledging it. Last week, Wallace said on ...
- Woman wins lawsuit after being fired while struggling with postpartum depressionon October 17, 2019 at 1:26 am
Woman wins lawsuit after being fired while struggling with postpartum depression originally appeared on goodmorningamerica.com Maria Alves thought the crippling anxiety and worry she said she felt ...
- Depression, anxiety can dampen efforts to recover from a heart attackon October 16, 2019 at 10:29 am
Recovering from a heart attack can be tough, but new research suggests that depression, anxiety and stress can make it even tougher. "Anxiety may lead to fear of another cardiac event and stop people ...
- Japan’s Changing Face of Depressionon October 16, 2019 at 10:13 am
That evening, the worker went home and collapsed in his living room. He felt like he couldn’t go to work anymore. The next day, his wife took him to the hospital, where he was diagnosed with ...
via Bing News